Like ryplasim (patients got over 5000 treatments with excellent results) also prometic patented plasma fractionating technology which is much better than the old Cohn process (look at potential of ivig) also presented great results re small molecules like 4050 results where better in human trials than they expected
then there's takeover that was well planned starting in 2018 and ivig writedown of 150 million in early 2019 starting takeover and THEY GET RID OF PIERRE KAURIN,OUR LEAD SCIENTIST LYNNE GAGNON AND JOHN MORAN AND THEY ESSENTIALLY STOPPED STUDIES ,SELL ASSETS PAID THEMSELVES HUGE SAKARIES PAID BACK THEIR LOANS AND
SELL PLASMA DIVISION FOR MINIMAL AMOUNT WEEKS BEFORE FDA APPROVED RYPLASIM
all retail investors invested in prometics because of ALL great results and potential that was presented to them via news releases and at agm's 3 years before takeover
who will judge believe prometic scientist/ceo or people who replaced them AFTER takeover